Clinical Trial Categories
Multi Cohort Trials
USO 21400
Avavilable at 1 location
A PHASE 2 CLINICAL STUDY OF TJ004309 IN COMBINATION WITH ATEZOLIZUMAB (TECENTRIQ®) IN PATIENTS WITH ADVANCED OR METASTATIC OVARIAN CANCERS AND SELECTED ADVANCED SOLID TUMORS
USO 20422
Avavilable at 12 locations
KRAS DetECT: KRAS mutation Detection to evaluate Eligibility for Clinical Trials